BIOVAIL LABS INTL
SpecialtyBIOVAIL LABS INTL is a specialty pharmaceutical company focused on Cardiovascular.
BIOVAIL LABS INTL's Key Drugs
BIOVAIL LABS INTL's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
BIOVAIL LABS INTL's Recent FDA Approvals
New NDA/BLA approvals for BIOVAIL LABS INTL over the last two years — novel drugs only, excluding generics and label supplements.
BIOVAIL LABS INTL's Therapeutic Areas
BIOVAIL LABS INTL's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BIOVAIL LABS INTL's Top Competitors
BIOVAIL LABS INTL's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
BIOVAIL LABS INTL Pipeline Snapshot
Active clinical trials for BIOVAIL LABS INTL across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1988-02-09
- Latest
- 2007-04-25
- Applications
- 4